Close Menu

thyroid cancer

In PNAS this week: epigenetic changes linked with high-altitude pulmonary edema, transcriptome profiling of maize leaf development, and more.

The firm also disclosed that it has paid $1.2 million in severance and bonuses related to its acquisition of Allegro Diagnostics.

Kura's clinical collaborators will conduct NGS analysis to identify patients with HRAS mutations and who may also respond to tipifarnib.

The company anticipates releasing initial data this year showing that is cancer of unknown primary origin test can successfully guide treatment decisions.

Veracyte's study raised concerns over using NGS mutational data in diagnosing thyroid nodules, while Interpace suggested a combination approach.

San Francisco-based Veracyte today announced that Blue Shield of California has issued a positive coverage policy for the firm's Afirma Gene Expression Classifier.

Veracyte reported after the close of the market on Thursday a 75 percent jump in revenues for the third quarter.

NEW YORK (GenomeWeb) – New thyroid cancer mutations reported recently by members of The Cancer Genome Atlas consortium are already finding their way into at least one sequencing-based genotyping test used to distinguish between benign thyroid nodules and thyroid malignancies.

NEW YORK (GenomeWeb) — Rosetta Genomics said today that it is collaborating with the Institute of Molecular Translational Medicine (IMTM) at Palacky University in the Czech Republic to validate and develop a new thyroid cancer diagnostic tool.

Originally published Oct. 10.

Pages

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.